Journal of Clinical Pharmacy and Therapeutics

Cover image for Vol. 37 Issue 1

February 2012

Volume 37, Issue 1

Pages 1–123

  1. Commentary

    1. Top of page
    2. Commentary
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. You have free access to this content
      Optimal therapy for reduction of lipoprotein(a) (pages 1–3)

      G. Lippi and G. Targher

      Version of Record online: 30 JAN 2011 | DOI: 10.1111/j.1365-2710.2011.01244.x

  2. Review Articles

    1. Top of page
    2. Commentary
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. You have free access to this content
      The evolving understanding of the analgesic mechanism of action of flupirtine (pages 4–6)

      R. B. Raffa and J. V. Pergolizzi Jr

      Version of Record online: 28 NOV 2010 | DOI: 10.1111/j.1365-2710.2010.01233.x

    2. You have free access to this content
  3. Original Articles

    1. Top of page
    2. Commentary
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. Effect of vitamins C and E on antioxidant status of breast-cancer patients undergoing chemotherapy (pages 22–26)

      N. Suhail, N. Bilal, H. Y. Khan, S. Hasan, S. Sharma, F. Khan, T. Mansoor and N. Banu

      Version of Record online: 4 JAN 2011 | DOI: 10.1111/j.1365-2710.2010.01237.x

    2. Analysis of antibiotic utilization and bacterial resistance changes in a surgical clinic of Clinical Centre, Nis (pages 32–36)

      R. Velickovic-Radovanovic, J. Petrovic, B. Kocic, S. Antic and R. Mitic

      Version of Record online: 7 FEB 2011 | DOI: 10.1111/j.1365-2710.2010.01241.x

    3. Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy (pages 37–44)

      U. Kirchmayer, N. Agabiti, V. Belleudi, M. Davoli, D. Fusco, M. Stafoggia, M. Arcà, A. P. Barone and C. A. Perucci

      Version of Record online: 6 FEB 2011 | DOI: 10.1111/j.1365-2710.2010.01242.x

    4. Renal impairment after laparoscopic radical nephrectomy affects hypoglycaemic therapy (pages 49–52)

      T. Mizuno, K. Ito, Y. Miyagawa, K. Kimura, Y. Suzuki, M. Mizuno, Y. Ito, Y. Funahashi, R. Hattori, M. Gotoh, Y. Noda and K. Yamada

      Version of Record online: 17 FEB 2011 | DOI: 10.1111/j.1365-2710.2011.01247.x

    5. Content variability of active drug substance in compounded oral 3,4-diaminopyridine products (pages 53–57)

      D. M. Green, A. C. Jones and K. R. Brain

      Version of Record online: 19 APR 2011 | DOI: 10.1111/j.1365-2710.2011.01249.x

    6. Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland (pages 58–64)

      A. Helin-Salmivaara, M.J. Korhonen, T. Alanen and R. Huupponen

      Version of Record online: 16 MAR 2011 | DOI: 10.1111/j.1365-2710.2011.01250.x

    7. Thiazolidenediones induce tumour-cell apoptosis through the Akt-GSK3β pathway (pages 65–70)

      H. Zhu, B. Han, X. Pan, H. Qi and L. Xu

      Version of Record online: 16 MAR 2011 | DOI: 10.1111/j.1365-2710.2011.01251.x

    8. A stability indicating assay for a combination of morphine sulphate with levomepromazine hydrochloride used in palliative care (pages 71–73)

      N. F. Al-Tannak, C. G. Cable, D. A. McArthur and D. G. Watson

      Version of Record online: 16 MAR 2011 | DOI: 10.1111/j.1365-2710.2011.01252.x

    9. Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies (pages 74–77)

      A. Hamada, R. Akiyoshi, J. Ishii, N. Hamada, C. Miyazaki, T. Hamada, Y. Ohwaki, R. Ikeda, M. Wada and K. Nakashima

      Version of Record online: 13 MAR 2011 | DOI: 10.1111/j.1365-2710.2011.01253.x

    10. Consumption of three most widely used analgesics in six European countries (pages 78–80)

      R. Hudec, L. Božeková and J. Tisoňová

      Version of Record online: 6 APR 2011 | DOI: 10.1111/j.1365-2710.2011.01256.x

  4. Pharmacokinetics

    1. Top of page
    2. Commentary
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. Evaluation of steady-state pharmacokinetic interactions between ritonavir-boosted BILR 355, a non-nucleoside reverse transcriptase inhibitor, and lamivudine/zidovudine in healthy subjects (pages 81–88)

      F. Huang, L. Allen, D. B. Huang, F. Moy, R. Vinisko, T. Nguyen, L. Rowland, T. R. MacGregor, M. A. Castles and P. Robinson

      Version of Record online: 5 DEC 2010 | DOI: 10.1111/j.1365-2710.2010.01235.x

    2. Rapid and validated fluorometric HPLC method for determination of gabapentin in human plasma and urine for clinical application (pages 89–94)

      T. Yagi, T. Naito, Y. Mino, Y. Takashina, K. Umemura and J. Kawakami

      Version of Record online: 30 JAN 2011 | DOI: 10.1111/j.1365-2710.2010.01243.x

  5. Pharmacogenetics

    1. Top of page
    2. Commentary
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. Cytochrome P450 3A4 genetic polymorphisms and post-operative fentanyl requirements (pages 100–104)

      P. C. S. Tan, S. K. Hassan, N. A. N. Mohamad and S. H. Gan

      Version of Record online: 3 DEC 2010 | DOI: 10.1111/j.1365-2710.2010.01232.x

    2. Frequency of CYP2C9 variant alleles, including CYP2C9*13 in a Korean population and effect on glimepiride pharmacokinetics (pages 105–111)

      H. W. Lee, M.-s. Lim, J. Lee, M.-Y. Jegal, D.-W. Kim, W.-K. Lee, I.-J. Jang, J.-G. Shin and Y.-R. Yoon

      Version of Record online: 5 JAN 2011 | DOI: 10.1111/j.1365-2710.2010.01238.x

    3. Influence of leukotriene pathway polymorphisms on clinical responses to montelukast in Japanese patients with asthma (pages 112–116)

      H. Kotani, R. Kishi, A. Mouri, T. Sashio, J. Shindo, A. Shiraki, T. Hiramatsu, S. Iwata, H. Taniguchi, O. Nishiyama, M. Iwata, R. Suzuki, H. Gonda, T. Niwa, M. Kondo, Y. Hasegawa, H. Kume and Y. Noda

      Version of Record online: 9 MAR 2011 | DOI: 10.1111/j.1365-2710.2011.01248.x

  6. Case Reports

    1. Top of page
    2. Commentary
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease (pages 117–121)

      Y. Horai, T. Miyamura, K. Shimada, S. Takahama, R. Minami, M. Yamamoto and E. Suematsu

      Version of Record online: 5 DEC 2010 | DOI: 10.1111/j.1365-2710.2010.01234.x

SEARCH

SEARCH BY CITATION